INTERNATIONAL PATENT: VACCINEX, INC. FILES APPLICATION FOR "USE OF ANTI-SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH FLT3 LIGAND TO INHIBIT TUMOR GROWTH AND METASTASIS"

GENEVA, April 20 -- VACCINEX, INC. (1895 Mt. Hope AvenueRochester, NY 14620) filed a patent application (PCT/US2025/050455) for "USE OF ANTI-SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH FLT3 LIGAND TO INHIBIT TUMOR GROWTH AND METASTASIS" on Oct 10, 2025. With publication no. WO/2026/080818, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EVANS, Elizabeth, E. (41 Main StreetBloomfield, NY 14469), ZAUDERER, Maurice (44 Woodland RoadPittsford, NY 14534)

Abstract: A combination therapy comprising a semaphorin-4D in...